Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.
Press releases published on August 1, 2025
Actxa Launches Core Smart Ring Sets Stage for Global Expansion
EIN Presswire
·
August 1, 2025
SINGAPORE, SINGAPORE, August 1, 2025 /EINPresswire.com/ -- Actxa, a Singapore-based deep tech company, today announced the launch of the Core Smart Ring, its first-ever smart ring. This is the first wearable under its newly unveiled Core series — a …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
HiCast Sports Partners with Jackie Robinson Training Complex, MLB.com to Provide Nike RBI World Series Free Livestream
EIN Presswire
·
August 1, 2025
Free livestream available Aug. 3-16 VERO BEACH, FL, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- HiCast Sports Network, a leading video streaming platform for youth and amateur sports, will provide free livestream viewing Aug. 3-16 to MLB.com and …
Halal Food Ingredients Market Size to Reach $108.9 Billion, by 2034 at 6.0% CAGR
EIN Presswire
·
August 1, 2025
Halal food ingredients market was valued at $58.4 billion in 2023, and is estimated to reach $108.9 billion by 2034, growing at a CAGR of 6.0% DELAWARE, DE, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- The growth of the halal ingredients market …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
GlobeNewswire
·
August 1, 2025
IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, …
Sirona Biochem Update to Shareholders on Financial Status and Operations
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company’s financial position and recent corporate developments. The …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Milanisti Channel.com: un grande record di pagine viste e visitatori unici a luglio 2025
EIN Presswire
·
August 1, 2025
MILANO, ITALY, August 1, 2025 /EINPresswire.com/ -- Grazie all'intensissimo lavoro di giornalisti giovani, appassionati di calcio e di Milan e grazie alla credibilità conquistata quotidianamente e costantemente sul campo (Authority score anch'essa in …
Peacemeal by Liying Peng Wins Bronze in A' Mobile Technology Awards
EIN Presswire
·
August 1, 2025
Innovative Wellness App Recognized for User-Centered Design and Compassionate Approach to Weight Gain Support COMO, CO, ITALY, August 1, 2025 /EINPresswire.com/ -- The A' Design Award, a highly prestigious and well-recognized award in the field of …
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“ImageneBio”), a clinical stage biotechnology company dedicated to developing treatments for immunological/autoimmune and inflammatory (“I…
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
GlobeNewswire
·
August 1, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025
GlobeNewswire
·
August 1, 2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 …
Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire
·
August 1, 2025
PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, …
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten …
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
GlobeNewswire
·
August 1, 2025
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic …
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
GlobeNewswire
·
August 1, 2025
Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non‑dilutive grant funding from KRHP LLC. WARREN, N.J., Aug. 01, 2025 …